- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Do | Filtronic - Agreement with SpaceX drives upgrades | 158 | Filtronic has signed a strategic partnership and commercial agreement with SpaceX which includes a production order worth £15.8m and warrants that could be exercised for up to 10% of existing share... ► Artikel lesen | ||
| Do | Checkit - Signposting the path to profitability | 146 | In a tough trading environment, Checkit managed to grow FY24 revenue by 17% and reduce EBITDA losses by nearly half. The company has had a positive start to FY25 with new contract wins and the launch... ► Artikel lesen | ||
| Do | Creo Medical - NHS data validates Speedboat's economic merit | 128 | Creo Medical has presented real-world evidence of the economic utility of its minimally invasive electrosurgical devices, based on NHS data from 130 submucosal dissection procedures using Creo's flagship... ► Artikel lesen | ||
| Mi | International Public Partnerships - Consistently and responsibly delivering | 216 | International Public Partnerships' (INPP's) FY23 results show that it continues to deliver consistent and predictable returns for investors, while delivering environmental and social benefits for the... ► Artikel lesen | ||
| Mi | Portobello SpA - Focus back on the operations | 131 | Portobello's FY23 results demonstrate the primary effects of the out-of-court settlement with respect to VAT and direct taxes (a higher year-end net debt position) and the secondary effects, such as... ► Artikel lesen | ||
| Mi | Intralot Integrated Lottery Systems and Services - Focus on business development in FY24 | 151 | Intralot enjoyed good underlying trends in performance in FY23 with encouraging trends in its main countries of focus and further progress on profitability. The much-improved balance sheet and extension... ► Artikel lesen | ||
| Di | Headlam Group - Strategy for growth in tougher market | 143 | Headlam Group has laid out an ambitious long-term revenue target of between £900m and £1bn, as it seeks to grow its share of the UK floor coverings distributor market. Despite a challenging backdrop... ► Artikel lesen | ||
| Mo | HydrogenOne Capital Growth - Hydrogen options maturing | 184 | HydrogenOne (HGEN) holds a distinctive and concentrated portfolio of assets across the entire hydrogen value chain (95% private, 2% public). In its FY23 results, its NAV and NAV per share increased... ► Artikel lesen | ||
| Mo | S&U - PBT ahead, encouraging volume trends | 121 | S&U reported FY24 PBT of £33.6m, down from £41.4m in FY23 on higher funding and regulatory costs and higher impairments in Advantage in H2. PBT was 2% ahead of our forecast as stronger revenues - up... ► Artikel lesen | ||
| Mo | Ceres Power Holdings - Strategic partnerships powering growth | 357 | Ceres Power Holdings' innovative technology uses electrolysis to produce green hydrogen and solid oxide fuel cells to generate power. In a year where it moved to the Main Market of the London Stock... ► Artikel lesen | ||
| Mo | Zalaris - Commencement of strategic review | 188 | Zalaris announced a strategic review process on 2 April, as the company explores potential opportunities to accelerate growth and maximise value for both customers and shareholders. The potential of... ► Artikel lesen | ||
| Mo | Borussia Dortmund - Helping itself | 262 | Borussia Dortmund's progress to the semi-final of the Champions League brings a further upgrade to profit guidance for FY24. In addition to helping the financial results of the current year, the relative... ► Artikel lesen | ||
| Mo | Basilea Pharmaceutica - Need for innovation against severe infections | 184 | At its recent capital markets day (CMD) and with the support of key opinion leaders, Basilea highlighted the rising need for innovative therapies to address serious fungal and bacterial infections.... ► Artikel lesen | ||
| 19.04. | discoverIE Group - FY24 EPS in line; good margin progress | 169 | discoverIE anticipates reporting FY24 underlying EPS in line with board expectations. After a period in mid-FY24 of working down inventory, customers appear to be reverting to normal ordering patterns... ► Artikel lesen | ||
| 18.04. | Ultimovacs - Steadfast commitment to UV1 progression | 151 | Despite the recent setback with the INITIUM trial (first-line treatment of patients with unresectable or metastatic malignant melanoma), Ultimovacs has reinstated its commitment to press on with its... ► Artikel lesen | ||
| 18.04. | OSE Immunotherapeutics - AbbVie deal clears antitrust hurdle | 200 | OSE has announced that its licence agreement with AbbVie has cleared antitrust review and has become effective. As previously noted, this is expected to support OSE's runway extension into 2026, past... ► Artikel lesen | ||
| 18.04. | Jersey Electricity - Decarbonisation fuelling growth | 198 | Jersey Electricity (JEL) is intensifying its focus on energy security and electrification across Jersey by creating opportunities to accelerate growth. It successfully navigated the volatile wholesale... ► Artikel lesen | ||
| 18.04. | Manx Financial Group - Executing on a high-growth strategy | 141 | Manx Financial Group (Manx) posted record PBT of £7m, a 35% increase year-on-year. Manx benefited from strong volumes, a full year contribution from Payment Assist Limited (PAL) and a £1.9m gain on... ► Artikel lesen | ||
| 18.04. | Carr's Group - An enhanced value-creation strategy | 147 | Carr's Group has announced an updated strategy that offers the potential for value realisation and creation from a number of avenues. These include: value realisation of the Engineering Division; the... ► Artikel lesen | ||
| 17.04. | Arcadium Lithium - When one plus one equals three | 788 | Alongside Albemarle and SQM, Arcadium Lithium is the third largest producer of downstream lithium chemicals outside China, capturing the full value chain from lithium resource to battery-grade lithium... ► Artikel lesen | ||
| 17.04. | ABO Energy - Global growth generates record net profit | 271 | ABO Energy reported strong financial results for FY23, as revenue grew by 29% y-o-y to €300m and net profit increased by 11% to €27.3m. Revenue growth was partially driven by a substantial increase... ► Artikel lesen | ||
| 17.04. | Next 15 Group - Baked in AI opportunities | 170 | Next 15 Group's net revenues grew 2.5% in the year to January, despite difficult markets. Adjusted operating margin rose from 20.2% to 21.0%, helped by head office cost savings. In common with much... ► Artikel lesen | ||
| 17.04. | Severfield - Multiple positives should excite investors | 158 | Severfield's trading update indicates that FY23 results are expected to slightly exceed market expectations and the company ends the year with a record UK and Europe order book. Furthermore, with a... ► Artikel lesen | ||
| 16.04. | IP Group - Several potential portfolio catalysts on the horizon | 200 | IP Group's NAV declined by 13% in total return (TR) terms in FY23, affected by continued soft valuations across venture capital (VC) markets, as well as funding delays at some of its holdings. That... ► Artikel lesen | ||
| 16.04. | Actinogen Medical - First patient dosed in Phase IIb XanaMIA study | 105 | Actinogen Medical announced that the first randomised patient in its Phase IIb XanaMIA trial of lead candidate Xanamem received their first treatment on Friday 12 April. This study is designed to enrol... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
